Skip to content

Aurobindo Pharma units recall products in US market for manufacturing issues

According to the latest Enforcement Report by the US Food and Drug Administration (USFDA), New Jersey-based Aurobindo Pharma USA Inc is recalling 9,504 bottles of Quinapril and Hydrochlorothiazide tablets.

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

en_USEnglish